HIT Consultant March 7, 2024
Syed Hamza Sohail

What You Should Know:

  • Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today announced expanded capabilities designed to help employers and health plans manage rising demand for anti-obesity medication such as glucagon-like peptide 1 (GLP-1) agonists and support safe, sustainable weight loss and cardiometabolic health improvement for members.
  • New features include helping plan sponsors and pharmacy benefit managers manage and optimize the growing complexity and costs associated with obesity management, as well as care coordination with non-Teladoc Health physicians and lab testing. The multidisciplinary care model is designed by clinicians experienced in obesity medicine and delivered with a tailored approach to weight management.

Teladoc Health Expands Comprehensive Weight Management Solution to Address Growing Obesity...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, Technology, Telehealth
Related Articles:
Amwell’s Roy Schoenberg talks about telehealth and broader views of virtual care
The telehealth background of Trump's FDA pick: 6 notes
Teladoc expands virtual sitter capabilities
AHA, others urge Congress to act on alternative payment models, avoid physician payment cut
Are telehealth visits for pediatric primary care associated with higher rates of health care utilization?

Share This Article